nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Penbutolol—HTR1A—Parkinson's disease	0.0199	0.176	CrCbGaD
Levobunolol—ADRB1—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.0188	0.0212	CbGpPWpGaD
Levobunolol—ADRB1—Monoamine GPCRs—HTR1A—Parkinson's disease	0.0176	0.0198	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—HTR1A—Parkinson's disease	0.0172	0.0194	CbGpPWpGaD
Levobunolol—Timolol—CYP2D6—Parkinson's disease	0.0172	0.152	CrCbGaD
Levobunolol—ADRB1—Monoamine GPCRs—DRD1—Parkinson's disease	0.017	0.0191	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—DRD1—Parkinson's disease	0.0166	0.0187	CbGpPWpGaD
Levobunolol—ADRB1—Monoamine GPCRs—DRD3—Parkinson's disease	0.0164	0.0185	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—DRD3—Parkinson's disease	0.0161	0.0181	CbGpPWpGaD
Levobunolol—Carteolol—CYP2D6—Parkinson's disease	0.0153	0.135	CrCbGaD
Levobunolol—ADRB1—Monoamine GPCRs—HTR7—Parkinson's disease	0.0149	0.0168	CbGpPWpGaD
Levobunolol—ADRB1—Monoamine GPCRs—DRD2—Parkinson's disease	0.0149	0.0168	CbGpPWpGaD
Levobunolol—ADRB1—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.0148	0.0167	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—HTR7—Parkinson's disease	0.0145	0.0164	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—DRD2—Parkinson's disease	0.0145	0.0164	CbGpPWpGaD
Levobunolol—ADRB2—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.0144	0.0163	CbGpPWpGaD
Levobunolol—Pindolol—HTR1A—Parkinson's disease	0.0143	0.127	CrCbGaD
Levobunolol—ADRB1—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.0143	0.0161	CbGpPWpGaD
Levobunolol—ADRB1—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.0142	0.016	CbGpPWpGaD
Levobunolol—ADRB2—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.014	0.0157	CbGpPWpGaD
Levobunolol—ADRB1—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.0138	0.0156	CbGpPWpGaD
Levobunolol—ADRB2—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.0135	0.0152	CbGpPWpGaD
Levobunolol—ADRB1—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.0132	0.0149	CbGpPWpGaD
Levobunolol—ADRB1—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.0125	0.0141	CbGpPWpGaD
Levobunolol—ADRB1—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.0125	0.0141	CbGpPWpGaD
Levobunolol—Timolol—ABCB1—Parkinson's disease	0.0123	0.108	CrCbGaD
Levobunolol—ADRB2—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.0122	0.0138	CbGpPWpGaD
Levobunolol—ADRB2—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.0122	0.0138	CbGpPWpGaD
Levobunolol—ADRB1—Calcium Regulation in the Cardiac Cell—GRK6—Parkinson's disease	0.0119	0.0134	CbGpPWpGaD
Levobunolol—ADRB1—Endothelin Pathways—EDN1—Parkinson's disease	0.0119	0.0134	CbGpPWpGaD
Levobunolol—ADRB2—Calcium Regulation in the Cardiac Cell—GRK6—Parkinson's disease	0.0116	0.0131	CbGpPWpGaD
Levobunolol—ADRB2—Arf6 signaling events—HGF—Parkinson's disease	0.011	0.0124	CbGpPWpGaD
Levobunolol—ADRB1—Melatonin metabolism and effects—APOE—Parkinson's disease	0.0107	0.0121	CbGpPWpGaD
Levobunolol—ADRB1—Monoamine GPCRs—HTR2A—Parkinson's disease	0.0104	0.0117	CbGpPWpGaD
Levobunolol—ADRB2—Monoamine GPCRs—HTR2A—Parkinson's disease	0.0102	0.0115	CbGpPWpGaD
Levobunolol—ADRB1—Calcium Regulation in the Cardiac Cell—GRK5—Parkinson's disease	0.00986	0.0111	CbGpPWpGaD
Levobunolol—Nadolol—ABCB1—Parkinson's disease	0.00975	0.0862	CrCbGaD
Levobunolol—ADRB2—Calcium Regulation in the Cardiac Cell—GRK5—Parkinson's disease	0.00965	0.0109	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Other—ADORA2A—Parkinson's disease	0.0088	0.00992	CbGpPWpGaD
Levobunolol—ADRB1—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.00875	0.00987	CbGpPWpGaD
Levobunolol—Pindolol—CYP2D6—Parkinson's disease	0.00859	0.0759	CrCbGaD
Levobunolol—ADRB2—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.00856	0.00965	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00839	0.00946	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00821	0.00925	CbGpPWpGaD
Levobunolol—Propranolol—HTR1A—Parkinson's disease	0.00781	0.069	CrCbGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.00719	0.0081	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Other—DRD3—Parkinson's disease	0.00714	0.00805	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.00703	0.00793	CbGpPWpGaD
Levobunolol—ADRB1—G alpha (s) signalling events—ADORA2A—Parkinson's disease	0.00702	0.00792	CbGpPWpGaD
Levobunolol—ADRB2—G alpha (s) signalling events—ADORA2A—Parkinson's disease	0.00687	0.00775	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Other—HTR7—Parkinson's disease	0.00646	0.00728	CbGpPWpGaD
Levobunolol—ADRB2—Arf6 trafficking events—INS—Parkinson's disease	0.00609	0.00687	CbGpPWpGaD
Levobunolol—ADRB1—G alpha (s) signalling events—DRD1—Parkinson's disease	0.00588	0.00664	CbGpPWpGaD
Levobunolol—ADRB2—G alpha (s) signalling events—DRD1—Parkinson's disease	0.00576	0.00649	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—GPR37—Parkinson's disease	0.00547	0.00617	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—GPR37—Parkinson's disease	0.00535	0.00604	CbGpPWpGaD
Levobunolol—ADRB1—G alpha (s) signalling events—HTR7—Parkinson's disease	0.00515	0.00581	CbGpPWpGaD
Levobunolol—ADRB2—G alpha (s) signalling events—HTR7—Parkinson's disease	0.00504	0.00569	CbGpPWpGaD
Levobunolol—Propranolol—CYP2D6—Parkinson's disease	0.00468	0.0414	CrCbGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00463	0.00522	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00453	0.00511	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Other—HTR2A—Parkinson's disease	0.00452	0.0051	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00424	0.00478	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00414	0.00467	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00391	0.00441	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00382	0.00431	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—GRM4—Parkinson's disease	0.00372	0.00419	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—GRM4—Parkinson's disease	0.00364	0.0041	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—PENK—Parkinson's disease	0.00353	0.00398	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—PENK—Parkinson's disease	0.00345	0.00389	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00339	0.00382	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00335	0.00378	CbGpPWpGaD
Levobunolol—Propranolol—ABCB1—Parkinson's disease	0.00334	0.0296	CrCbGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00332	0.00374	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00328	0.00369	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00327	0.00369	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—PDYN—Parkinson's disease	0.00323	0.00364	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.0032	0.00361	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00317	0.00358	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—PDYN—Parkinson's disease	0.00316	0.00356	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.0031	0.0035	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00309	0.00349	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00303	0.00341	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—GRM5—Parkinson's disease	0.003	0.00338	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—GRM5—Parkinson's disease	0.00293	0.00331	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00291	0.00328	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00287	0.00323	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00287	0.00323	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00286	0.00323	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00284	0.0032	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GPR37—Parkinson's disease	0.00281	0.00317	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00281	0.00317	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00281	0.00316	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00281	0.00316	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00281	0.00316	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.0028	0.00316	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—DGKQ—Parkinson's disease	0.00275	0.0031	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GPR37—Parkinson's disease	0.00275	0.0031	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00274	0.00309	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00272	0.00306	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00266	0.003	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00257	0.0029	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00255	0.00287	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00251	0.00283	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00249	0.00281	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00246	0.00277	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00246	0.00277	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.0024	0.00271	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.0024	0.00271	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00234	0.00264	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—GRK5—Parkinson's disease	0.00229	0.00259	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00221	0.00249	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—TAC1—Parkinson's disease	0.00218	0.00246	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—HTR1A—Parkinson's disease	0.00216	0.00244	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—DRD1—Parkinson's disease	0.00214	0.00241	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—TAC1—Parkinson's disease	0.00213	0.0024	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GRK5—Parkinson's disease	0.00213	0.0024	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—GRM4—Parkinson's disease	0.0021	0.00237	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—DRD1—Parkinson's disease	0.00209	0.00236	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GRK5—Parkinson's disease	0.00208	0.00235	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—DRD3—Parkinson's disease	0.00207	0.00233	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—GRM4—Parkinson's disease	0.00206	0.00232	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—DRD3—Parkinson's disease	0.00202	0.00228	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00201	0.00227	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—VPS35—Parkinson's disease	0.002	0.00226	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PENK—Parkinson's disease	0.00199	0.00225	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00197	0.00222	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00197	0.00222	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—VPS35—Parkinson's disease	0.00196	0.00221	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PENK—Parkinson's disease	0.00195	0.0022	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00192	0.00217	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GRM4—Parkinson's disease	0.00191	0.00215	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—HTR7—Parkinson's disease	0.00187	0.00211	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—DRD2—Parkinson's disease	0.00187	0.00211	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GRM4—Parkinson's disease	0.00187	0.00211	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—HTR7—Parkinson's disease	0.00183	0.00206	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—DRD2—Parkinson's disease	0.00183	0.00206	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00182	0.00206	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PENK—Parkinson's disease	0.00181	0.00204	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PDYN—Parkinson's disease	0.00178	0.00201	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	0.00177	0.002	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00172	0.00194	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—GRM5—Parkinson's disease	0.00169	0.00191	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00168	0.0019	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	0.00166	0.00187	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	0.00166	0.00187	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	0.00166	0.00187	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	0.00166	0.00187	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	0.00162	0.00183	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	0.00162	0.00183	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	0.00162	0.00183	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	0.00154	0.00174	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00152	0.00171	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	0.00151	0.0017	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	0.0015	0.00169	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00148	0.00167	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	0.00147	0.00165	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00144	0.00162	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00141	0.00159	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	0.00133	0.0015	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00131	0.00148	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00131	0.00148	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	0.0013	0.00146	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	0.00128	0.00145	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00128	0.00144	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	0.00126	0.00142	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00125	0.00141	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	0.00123	0.00139	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	0.00123	0.00139	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00122	0.00138	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00121	0.00136	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	0.0012	0.00136	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	0.00118	0.00133	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	0.00117	0.00132	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	0.00114	0.00129	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	0.00114	0.00128	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	0.00113	0.00127	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	0.00112	0.00126	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	0.00111	0.00125	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	0.0011	0.00124	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	0.0011	0.00124	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	0.00109	0.00123	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00109	0.00123	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	0.00107	0.00121	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PENK—Parkinson's disease	0.00107	0.00121	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MAG—Parkinson's disease	0.00107	0.00121	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00107	0.0012	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	0.00106	0.0012	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	0.00106	0.00119	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	0.00106	0.00119	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MAG—Parkinson's disease	0.00105	0.00118	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PENK—Parkinson's disease	0.00105	0.00118	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	0.00104	0.00117	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	0.00103	0.00117	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	0.00103	0.00117	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000992	0.00112	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	0.000978	0.0011	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00097	0.00109	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	0.00096	0.00108	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	0.00096	0.00108	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	0.000956	0.00108	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	0.000939	0.00106	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	0.000939	0.00106	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	0.000919	0.00104	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	0.000909	0.00102	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	0.000899	0.00101	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	0.000889	0.001	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000847	0.000955	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000828	0.000934	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	0.000797	0.000899	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	0.00078	0.000879	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000773	0.000872	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	0.000769	0.000867	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000756	0.000853	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	0.000752	0.000848	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000741	0.000835	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000725	0.000817	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—INSR—Parkinson's disease	0.000713	0.000804	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—INSR—Parkinson's disease	0.000698	0.000787	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGB—Parkinson's disease	0.000674	0.00076	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000673	0.000758	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	0.000671	0.000756	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	0.00066	0.000745	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGB—Parkinson's disease	0.000659	0.000744	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000658	0.000742	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	0.000656	0.00074	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	0.000648	0.00073	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	0.000646	0.000728	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	0.000634	0.000714	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	0.000627	0.000707	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	0.000614	0.000692	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000586	0.00066	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000573	0.000646	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	0.000567	0.00064	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	0.000567	0.00064	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	0.000555	0.000626	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	0.000555	0.000626	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	0.000475	0.000536	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	0.000465	0.000524	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	0.00046	0.000518	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	0.000454	0.000512	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	0.00045	0.000507	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	0.000444	0.000501	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	0.000417	0.000471	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	0.000408	0.00046	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	0.000397	0.000448	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	0.000389	0.000438	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	0.000369	0.000417	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	0.000361	0.000407	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—INS—Parkinson's disease	0.000316	0.000356	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—INS—Parkinson's disease	0.000309	0.000348	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	0.000235	0.000265	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	0.000233	0.000263	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	0.00023	0.000259	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	0.000228	0.000257	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	0.000216	0.000243	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	0.000211	0.000238	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	0.000138	0.000155	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	0.000135	0.000152	CbGpPWpGaD
